JMRS ASMIRT CPD Q&A - Radiation Therapy

JavaScript isn't enabled in your browser, so this file can't be opened. Enable and reload.

JMRS ASMIRT CPD Q&A - Radiation Therapy - September 2023

Maximise your CPD by reading the following selected Radiation Therapy article and answer the five questions.

Continuing Professional Development Q&A - Radiation Therapy

Routine Prophylactic Percutaneous Endoscopic Gastrostomy in Head and Neck Cancers with Bilateral Neck Irradiation: A Regional Cancer Experience in New Zealand

Fong SC, Pandey R, Rajaretnam M, Delaibatiki M, Peel DNY.

(2023) J Med Radiat Sci.

https://doi.org/10.1002/jmrs.699

1. Which statement best describes the current guidelines regarding the use of prophylactic percutaneous endoscopic gastrostomy (PEG) tubes in head and neck cancer patients? *

1 point

a. Prophylactic PEG tubes are recommended for all head and neck cancer patients.

b. Prophylactic PEG tubes are discouraged due to the high risk of infection.

c. Prophylactic PEG tube placement is made on an individual basis, considering the patient's overall health, treatment plan, and anticipated difficulty with oral intake.

d. Prophylactic PEG tubes are only used for palliative care.

2. What is the Subjective Global Assessment of nutritional status? *

1 point

a. A tool used to assess nutritional status based on objective measures such as BMI.

b. A tool used to assess nutritional status based on subjective measures such as patient history and physical examination.

c. A tool used to assess tumour characteristics based on imaging studies.

d. A tool used to assess treatment response based on blood tests.

3. What is the role of a multidisciplinary team in cancer care? *

1 point

a. To provide emotional support for patients during treatment.

b. To evaluate the effectiveness of PEGs.

c. To determine the best treatment regimen for cancer patients.

d. To determine the need for a PEG.

4. According to this study, what was the most frequent complication experienced by patients with PEGs? *

1 point

a. Peristomal infection

b. Bowel perforation and ileus

c. Significant pain after PEG insertion

d. Mild leakage from the PEG

5. According to the findings of this study, which of the following statements is false? *

1 point

a. Weight loss and hospitalisation rates among head and neck cancer patients are consistent with previous studies.

b. Prophylactic PEG procedures have high long-term dependence among head and neck cancer patients.

c. Xerostomia was the main reason for grade 1 and 2 late dysphagia in patients.

d. Chemoradiation therapy was the most common treatment among the patients.

Recommended further reading:

1. Petkar I, Rooney K, Roe JW, Patterson JM, Bernstein D, Tyler JM, Emson MA, Morden JP, et. al. DARS: a phase III randomised multicentre study of dysphagia- optimised intensity- modulated radiotherapy (Do-IMRT) versus standard intensity- modulated radiotherapy (S-IMRT) in head and neck cancer. BMC Cancer. 2016 Oct 6;16(1):770. doi: 10.1186/s12885-016-2813-0.

2. Anderson NJ, Jackson JE, Smith JG, Wada M, Schneider M, Poulsen M, Rolfo M, Fahandej M, et. al. Pretreatment risk stratification of feeding tube use in patients treated with intensity-modulated radiotherapy for head and neck cancer. Head Neck. 2018 Oct;40(10):2181-2192. doi: 10.1002/hed.25316.

3. Bishop S, Reed WM. The provision of enteral nutritional support during definitive chemoradiotherapy in head and neck cancer patients. J Med Radiat Sci. 2015 Dec;62(4):267-76. doi: 10.1002/jmrs.132.

This content was created in conjunction with the Australian Society of Medical Imaging and Radiation Therapy (ASMIRT) CPD Program.

Self-claim your CPD

To retain evidence of your CPD, select SUBMIT below, then VIEW SCORE. Print as a pdf and save to your CPD records.

Submit

Clear form

This content is neither created nor endorsed by Google. Report Abuse - Terms of Service - Privacy Policy

Forms